Now, researchers in a lab at the University of Minnesota, using a drug called CD200AR-L, have developed their own vaccine to ...

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, June 11. /TASS/. Over three mln doses ...

(ABC 6 News) — A new vaccine is being tested in the battle against childhood brain cancer. Researchers at the University of ...

Children’s Minnesota is testing the safety of a new vaccine combination to combat one of the deadliest pediatric cancers, which could give new hope for children who would otherwise typically die ...

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, August 14. /TASS/. No deaths related to ...

Peptides provide a good platform to develop efficient cancer vaccines or therapeutic agents that can specifically disrupt the network of signaling in this group of receptors. Peptide ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

US-based biotech company Vaxxinity has revealed positive data from part B of its Phase I study with its Parkinson’s vaccine UB-312, demonstrating a 20% reduction in toxic protein levels among ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching ...